CASCADIAN THERAPEUTICS INC - COM NEW (CASC)

CUSIP: 14740B606

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
40,606,477
Share change
+26,331,597
Total reported value
$168,106,691
Put/Call ratio
0%
Price per share
$4.14
Number of holders
67
Value change
+$109,037,876
Number of buys
52
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 14740B606?
CUSIP 14740B606 identifies CASC - CASCADIAN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM NEW (CASC) as of Q1 2017

As of 31 Mar 2017, CASCADIAN THERAPEUTICS INC - COM NEW (CASC) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 40,606,477 shares. The largest 10 holders included NEA Management Company, LLC, BAUPOST GROUP LLC/MA, Redmile Group, LLC, BVF INC/IL, EcoR1 Capital, LLC, venBio Select Advisor LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Abingworth LLP, and QVT Financial LP. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.